Atlas Trials

Randomized Trial for Optimal Number of Passes Required for Molecular Profiling During EUS-FNB of Pancreatic Cancer

Clinical trial NCT05043532 · UNKNOWN

Trial details

NCT number
NCT05043532
Sponsor
Orlando Health, Inc.
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Pancreatic CancerPancreatic NeoplasmsAdenocarcinoma of the Pancreas
Start date
2021-08-18
Primary completion
2023-03-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.